Skip to main content
. 2023 Feb 13;14:1097139. doi: 10.3389/fendo.2023.1097139

Table 4.

Glycemic control and treatment of patients undergoing total pancreatectomy in long-term follow-up period categorized by preoperative glycemic status.

Characteristics Total NDG With pre-op DM P value
SDG LDG
N 80 (100) 34 (42.5) 17 (21.3) 29 (36.3)
Age at last follow-up (years) 62.59 ± 10.41 60.53 ± 11.19c 61.29 ± 12.10 65.76 ± 7.61a 0.079
BMI (kg/m2) 20.33 ± 2.39 20.00 ± 2.31 20.03 ± 2.45 20.89 ± 2.44 0.290
HbA1c (%) 7.43 ± 0.76 7.32 ± 0.83 7.77 ± 0.88 7.36 ± 0.52 0.193
Insulin regimen 0.411
 MDI 63 (78.8) 28 (82.4) 12 (70.6) 23 (79.3)
 Premixed insulin 3 (3.8) 0 2 (11.8) 1 (3.4)
 Insulin pump 14 (17.5) 6 (17.6) 3 (17.6) 5 (17.2)
 Daily insulin dose (units/kg/day) 0.49 ± 0.19 0.42 ± 0.12c 0.42 ± 0.17c 0.60 ± 0.21ab < 0.001
 Daily insulin dose (units/day) 27.09 ± 11.88 23.00 ± 7.57c 22.98 ± 9.41c 34.28 ± 14.00ab < 0.001
 Basal percentage (%) 39.4 ± 16.4 37.2 ± 16.6 45.6 ± 17.4 38.4 ± 15.3 0.208
Insulin pump
 N 14 (100) 9 (64.3)* 5 (35.7)
 Daily insulin dose (units/kg/day) 0.44 ± 0.14 0.38 ± 0.10 0.53 ± 0.15 0.043
 Daily insulin dose (units/day) 24.81 ± 8.05 22.02 ± 6.97 29.83 ± 8.02 0.081
 Basal percentage (%) 44.1 ± 14.5 43.4 ± 13.5 45.9 ± 17.2 0.743
Combined oral antidiabetic agent 7 (8.8) 1 (2.9) 1 (5.9) 5 (17.2) 0.222
 Metformin 3 (3.8) 0 0 3 (10.3)
 α-glucosidase inhibitors 4 (5.0) 1 (2.9) 1 (5.9) 2 (6.9)

Data are presented as mean ± SD or number (percentage).

pre-op, preoperative; DM, diabetes mellitus; NDG, nondiabetic group; SDG, short-duration diabetic group; LDG, long-duration diabetic group; BMI, body mass index; HbA1c, glycosylated hemoglobin A1c; MDI, multiple daily insulin injections.

*Including seven preoperative nondiabetic patients and two short-duration diabetic patients.

aP < 0.05 vs NDG. bP < 0.05 vs SDG. cP < 0.05 vs LDG.

P values < 0.05 were shown in bold.